© 2024, Netherlands Foreign Investment Agency, Government of the Netherlands. All Rights Reserved.
Privacy Policy |
Terms of Use
This event is constituted by three exhibitions:
See the full program and register here.
Meet with the Invest in Holland Life Sciences & Health team at BioJapan, October 9-11! We’d be happy to start the conversation on business opportunities in Regenerative Medicine, Cell & Gene Therapy, Organoids, Organ-on-a-Chip and Digital Health in the Netherlands. Come and join us at the Netherlands Pavilion or reach out to our Life Sciences & Health team to schedule a meeting in advance.
The Netherlands ranks among the top 5 in the world in the field of regenerative medicine and the Netherlands is now one of the few places in Europe where (stem) cell therapy is also applied and developed clinically. In the last years several foreign companies have established European cell therapy manufacturing and R&D facilities in the Netherlands, including Kite, Fujifilm Irvine Scientific and Bristol Myers Squibb (BMS). The Netherlands’ high concentration of world-leading research talent, its business-oriented R&D facilities, startups and multinationals, and a supportive government, all make the Netherlands an attractive country for cell and gene therapy companies.
Learn more about the Dutch Biotech Ecosystem or how the Netherlands is advancing digital health care, and the many international life sciences companies that found fertile ground in the Netherlands to accelerate their business and benefit people and the planet.
Interested in opportunities for your life sciences & health company in the Netherlands? More information can be found in our Dutch Life Sciences & Health Magazine.
日本語はこちら